Published in Intern Med on March 01, 2011
The development and psychometric validation of the central sensitization inventory. Pain Pract (2011) 1.01
Development and validation of new disease-specific measures of somatization and comorbidity in IBS. J Psychosom Res (2012) 0.78
Prevalence of symptomatic pelvic floor disorders in US women. JAMA (2008) 7.81
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ (2008) 6.97
AGA technical review on irritable bowel syndrome. Gastroenterology (2002) 6.76
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology (2003) 3.77
Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology (2006) 2.98
Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol (2011) 2.83
Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement. Am J Gastroenterol (2006) 2.71
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut (2011) 2.66
Design of treatment trials for functional gastrointestinal disorders. Gastroenterology (2006) 2.58
Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology (2006) 2.51
Comorbidity in irritable bowel syndrome. Am J Gastroenterol (2007) 2.31
Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol (2014) 2.30
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
Endoscopic third ventriculostomy and choroid plexus cauterization in infants with hydrocephalus: a retrospective Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr (2014) 2.27
Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum (2009) 2.24
The digital rectal examination: a multicenter survey of physicians' and students' perceptions and practice patterns. Am J Gastroenterol (2012) 2.19
Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol (2010) 2.12
Fetoscopic Repair of Meningomyelocele. Obstet Gynecol (2015) 2.07
Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology (2005) 2.05
Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology (2006) 1.97
"Keystone" approach for intracranial nasofrontal dermoid sinuses. Plast Reconstr Surg (2005) 1.89
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology (2011) 1.88
Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol (2011) 1.88
A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol (2009) 1.85
Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol (2008) 1.85
Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol (2004) 1.82
Personality and the risk of cancer. J Natl Cancer Inst (2003) 1.81
Publication patterns of oral and poster presentations at the annual meetings of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons. J Neurosurg (2011) 1.73
IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. Am J Gastroenterol (2011) 1.72
Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum (2007) 1.69
Asian consensus report on functional dyspepsia. J Gastroenterol Hepatol (2012) 1.66
Adequate relief in a treatment trial with IBS patients: a prospective assessment. Am J Gastroenterol (2009) 1.64
Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol (2010) 1.64
Risk factors for fecal incontinence in older women. Am J Gastroenterol (2012) 1.64
The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol (2007) 1.60
Partner burden in irritable bowel syndrome. Clin Gastroenterol Hepatol (2012) 1.59
Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol (2007) 1.54
Decompression of idiopathic lumbar epidural lipomatosis: diagnostic magnetic resonance imaging evaluation and review of the literature. J Neurosurg Spine (2006) 1.54
Cognitive-behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms. Am J Gastroenterol (2010) 1.54
Posterior reversible encephalopathy syndrome during posterior fossa tumor resection in a child. J Neurosurg Pediatr (2010) 1.52
Computed tomography morphometric analysis for C-1 lateral mass screw placement in children. Clinical article. J Neurosurg Pediatr (2009) 1.52
The impact of the changing health care environment on the health and well-being of faculty at four medical schools. Acad Med (2006) 1.50
Here's my phone number, don't call me: physician accessibility in the cell phone and e-mail era. Dig Dis Sci (2010) 1.48
Intraoperative monitoring of motor evoked potentials in very young children. J Neurosurg Pediatr (2011) 1.46
Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol (2007) 1.44
Management of shunt infections: a multicenter pilot study. J Neurosurg (2006) 1.43
Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence. Dis Colon Rectum (2005) 1.43
Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol (2005) 1.41
Abnormal relationship between dissociation and hypnotic susceptibility in irritable bowel syndrome. Scand J Gastroenterol (2006) 1.41
Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE study. Am J Gastroenterol (2012) 1.41
Safety and efficacy of long-term maintenance therapy with oral dose of rabeprazole 10 mg once daily in Japanese patients with reflux esophagitis. Intern Med (2011) 1.41
Effectiveness of a clinical pathway for patients with cerebrospinal fluid shunt malfunction. J Neurosurg Pediatr (2010) 1.40
Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci (2004) 1.39
Extracranial traumatic carotid artery dissections in children: a review of current diagnosis and treatment options. J Neurosurg Pediatr (2008) 1.39
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology (2016) 1.39
Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med (2008) 1.33
Validation of a measure of protective parent responses to children's pain. Clin J Pain (2006) 1.31
Fecal incontinence in primary care: prevalence, diagnosis, and health care utilization. Am J Obstet Gynecol (2010) 1.29
Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol (2008) 1.29
Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci (2002) 1.28
Routine imaging in patients with ventriculopleural shunts: lessons learned from a case of tension hydrothorax. J Neurosurg Pediatr (2008) 1.27
Specific brain processing of facial expressions in people with alexithymia: an H2 15O-PET study. Brain (2003) 1.26
Pilot study on the effect of linaclotide in patients with chronic constipation. Am J Gastroenterol (2009) 1.26
Factors related to long-term outcome after decompressive surgery for ossification of the ligamentum flavum of the thoracic spine. J Neurosurg (2003) 1.25
Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil (2011) 1.25
A multicenter retrospective comparison of conversion from temporary to permanent cerebrospinal fluid diversion in very low birth weight infants with posthemorrhagic hydrocephalus. J Neurosurg Pediatr (2009) 1.25
Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol (2010) 1.23
Relationship of abuse history to functional gastrointestinal disorders and symptoms: some possible mediating mechanisms. Trauma Violence Abuse (2007) 1.22
Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol (2011) 1.22
A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol (2008) 1.22
Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology (2007) 1.22
A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol (2012) 1.21
Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol (2009) 1.20
Bowel symptoms in women 1 year after sacrocolpopexy. Am J Obstet Gynecol (2007) 1.19
Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series. J Bone Miner Metab (2012) 1.18
Clinical features of cauda equina tumors requiring surgical treatment. Tohoku J Exp Med (2006) 1.17